Georgia Senate Bill SB323

Georgia 2025-2026 Regular Session

• Introduced: 3/4/25
• Refer: 3/6/25

Caption

Health, Insurance, and Professions and Businesses; medically necessary tests for metal allergies and metal sensitivities to be administered prior to any cardiovascular, dental, or orthopedic surgery involving the insertion of a metal implant; provide

Impact

If enacted, SB323 will amend existing laws in Georgia by requiring health benefit policies to cover the costs associated with these tests starting July 1, 2025. This change will integrate allergy testing into standard pre-operative procedures for several surgical types, amending Title 33 of the Official Code of Georgia Annotated relating to insurance. The mandate is expected to contribute significantly to healthcare practices across the state, compelling insurers to accommodate coverage for these medically necessary tests, thereby potentially increasing healthcare costs. However, it also has the potential to decrease the incidence of post-surgical complications due to unrecognized allergies.

Summary

Senate Bill 323 aims to enhance patient safety prior to cardiovascular, dental, or orthopedic surgeries involving metal implants by mandating the administration of medically necessary tests for metal allergies and sensitivities. The bill requires healthcare providers to inquire about patients' metal allergies before such surgeries and necessitates testing if a patient discloses such allergies. This proactive measure is designed to minimize the risk of complications related to metal implants, which can include adverse reactions in susceptible individuals. By ensuring that doctors are aware of potential allergies, the legislation seeks to protect patient welfare and improve surgical outcomes.

Contention

The bill has sparked discussions regarding the financial implications for healthcare providers and insurers, particularly concerning the coverage requirements and whether they could lead to increased premiums. Some healthcare professionals express concerns about the administrative burden of complying with these new regulations. Additionally, questions around whether the state government or healthcare providers will be held liable in cases where allergic reactions occur despite adherence to testing protocols are also under discussion. These issues encapsulate the ongoing debate between ensuring patient safety and managing the costs associated with healthcare regulations.